Acurx Pharmaceuticals Llc Stock Buy Hold or Sell Recommendation
| ACXP Stock | USD 1.35 0.05 3.85% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Acurx Pharmaceuticals LLC is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Acurx Pharmaceuticals LLC given historical horizon and risk tolerance towards Acurx Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Acurx Pharmaceuticals LLC, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Acurx Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Acurx and provide practical buy, sell, or hold advice based on investors' constraints. Acurx Pharmaceuticals LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Acurx |
Execute Acurx Pharmaceuticals Buy or Sell Advice
The Acurx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acurx Pharmaceuticals LLC. Macroaxis does not own or have any residual interests in Acurx Pharmaceuticals LLC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acurx Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Acurx Pharmaceuticals Trading Alerts and Improvement Suggestions
| Acurx Pharmaceuticals generated a negative expected return over the last 90 days | |
| Acurx Pharmaceuticals may become a speculative penny stock | |
| Acurx Pharmaceuticals has high historical volatility and very poor performance | |
| Acurx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (14.58 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Acurx Pharmaceuticals LLC currently holds about 9.09 M in cash with (9.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8. | |
| Roughly 15.0% of the company shares are held by company insiders | |
| Latest headline from benzinga.com: Bitcoin Hits New All-Time High Above 98,000 As Spot ETFs Crack 100 Billion Net Asset Value Milestone |
Acurx Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Acurx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Acurx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Acurx Pharmaceuticals Returns Distribution Density
The distribution of Acurx Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Acurx Pharmaceuticals' future price movements. The chart of the probability distribution of Acurx Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Acurx Pharmaceuticals LLC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acurx Pharmaceuticals returns is essential to provide solid investment advice for Acurx Pharmaceuticals.
| Mean Return | -0.82 | Value At Risk | -6.47 | Potential Upside | 2.82 | Standard Deviation | 3.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acurx Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Acurx Stock Institutional Investors
The Acurx Pharmaceuticals' institutional investors refer to entities that pool money to purchase Acurx Pharmaceuticals' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Patriot Financial Group Insurance Agency, Llc | 2024-09-30 | 10.4 K | Tocqueville Asset Management L.p. | 2024-09-30 | 10 K | Semmax Financial Advisors Inc. | 2024-06-30 | 5.9 K | Group One Trading, Lp | 2024-06-30 | 5.2 K | Tower Research Capital Llc | 2024-06-30 | 4.1 K | Cornerstone Planning Group Llc | 2024-06-30 | 3.3 K | Simplex Trading, Llc | 2024-06-30 | 2.9 K | Northwestern Mutual Wealth Management Co | 2024-06-30 | 1.6 K | Ubs Group Ag | 2024-06-30 | 881 | Vanguard Group Inc | 2024-09-30 | 529.3 K | Prospect Financial Services Llc | 2024-09-30 | 295.1 K |
Acurx Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Acurx Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Acurx Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Acurx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.91 | |
β | Beta against Dow Jones | 0.75 | |
σ | Overall volatility | 3.45 | |
Ir | Information ratio | -0.28 |
Acurx Pharmaceuticals Volatility Alert
Acurx Pharmaceuticals LLC exhibits very low volatility with skewness of -0.89 and kurtosis of 9.85. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Acurx Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Acurx Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Acurx Pharmaceuticals Fundamentals Vs Peers
Comparing Acurx Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Acurx Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Acurx Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Acurx Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Acurx Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Acurx Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Acurx Pharmaceuticals to competition |
| Fundamentals | Acurx Pharmaceuticals | Peer Average |
| Return On Equity | -3.47 | -0.31 |
| Return On Asset | -1.32 | -0.14 |
| Current Valuation | 16.2 M | 16.62 B |
| Shares Outstanding | 16.89 M | 571.82 M |
| Shares Owned By Insiders | 14.80 % | 10.09 % |
| Shares Owned By Institutions | 11.96 % | 39.21 % |
| Number Of Shares Shorted | 474.48 K | 4.71 M |
| Price To Book | 8.24 X | 9.51 X |
| EBITDA | (14.58 M) | 3.9 B |
| Net Income | (14.58 M) | 570.98 M |
| Cash And Equivalents | 9.09 M | 2.7 B |
| Cash Per Share | 0.80 X | 5.01 X |
| Total Debt | 3.04 M | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 19.43 X | 2.16 X |
| Book Value Per Share | 0.32 X | 1.93 K |
| Cash Flow From Operations | (9.8 M) | 971.22 M |
| Short Ratio | 12.59 X | 4.00 X |
| Earnings Per Share | (1.09) X | 3.12 X |
| Target Price | 11.19 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | -1.72 | -0.15 |
| Market Capitalization | 21.96 M | 19.03 B |
| Total Asset | 7.71 M | 29.47 B |
| Retained Earnings | (53.22 M) | 9.33 B |
| Working Capital | 4.67 M | 1.48 B |
| Net Asset | 7.71 M |
Note: Acquisition by Donohue James J. of 50000 shares of Acurx Pharmaceuticals at 6.18 subject to Rule 16b-3 [view details]
Acurx Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acurx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 16643.0 | |||
| Daily Balance Of Power | 0.3846 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 1.37 | |||
| Day Typical Price | 1.36 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.05 |
About Acurx Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Acurx Pharmaceuticals LLC? Buying financial instruments such as Acurx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Acurx Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Funds Thematic Idea Now
Precious Metals Funds
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.